# Team Inc: financial statements, quarterly

TISI · NYSE · CIK 318833 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tisi.md) · [Financials](/companies/tisi/financials.md) · [Filings](/companies/tisi/filings.md) · [Insiders](/companies/tisi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tisi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [207](/filings/0000318833-24-000074.md) | [214 d](/filings/0000318833-25-000015.md) | [200](/filings/0000318833-25-000037.md) | [229](/filings/0000318833-25-000057.md) | [211](/filings/0000318833-25-000070.md) | [213 d](/filings/0000318833-26-000007.md) | [199](/filings/0000318833-26-000024.md) | [248](/filings/0000318833-26-000054.md) | [225](/filings/0000318833-25-000070.md) | [225 d](/filings/0000318833-26-000007.md) | [215](/filings/0000318833-26-000024.md) | [229](/filings/0000318833-26-000054.md) |
| Cost of revenue | $m | [154](/filings/0000318833-24-000074.md) | [164 d](/filings/0000318833-25-000015.md) | [151](/filings/0000318833-25-000037.md) | [165](/filings/0000318833-25-000057.md) | [157](/filings/0000318833-25-000070.md) | [156 d](/filings/0000318833-26-000007.md) | [151](/filings/0000318833-25-000037.md) | [180](/filings/0000318833-25-000057.md) | [167](/filings/0000318833-25-000070.md) | [167 d](/filings/0000318833-26-000007.md) | not reported | not reported |
| Gross profit | $m | [52.8](/filings/0000318833-24-000074.md) | [50.4 d](/filings/0000318833-25-000015.md) | [48.7](/filings/0000318833-25-000037.md) | [63.6](/filings/0000318833-25-000057.md) | [53.5](/filings/0000318833-25-000070.md) | [57.3 d](/filings/0000318833-26-000007.md) | [47.3](/filings/0000318833-26-000024.md) | [68.1](/filings/0000318833-26-000054.md) | [58.0](/filings/0000318833-25-000070.md) | [58.3 d](/filings/0000318833-26-000007.md) | [50.2](/filings/0000318833-26-000024.md) | [54.4](/filings/0000318833-26-000054.md) |
| Selling, general and administrative | $m | [54.0](/filings/0000318833-24-000074.md) | [59.3 d](/filings/0000318833-25-000015.md) | [55.1](/filings/0000318833-25-000037.md) | [52.4](/filings/0000318833-25-000057.md) | [50.4](/filings/0000318833-25-000070.md) | [55.1 d](/filings/0000318833-26-000007.md) | [48.0](/filings/0000318833-26-000024.md) | [50.6](/filings/0000318833-26-000054.md) | [56.7](/filings/0000318833-25-000070.md) | [51.7 d](/filings/0000318833-26-000007.md) | [48.1](/filings/0000318833-26-000024.md) | [46.8](/filings/0000318833-26-000054.md) |
| Operating income | $m | [(1.3)](/filings/0000318833-24-000074.md) | [(8.9) d](/filings/0000318833-25-000015.md) | [(6.4)](/filings/0000318833-25-000037.md) | [11.2](/filings/0000318833-25-000057.md) | [3.2](/filings/0000318833-25-000070.md) | [2.2 d](/filings/0000318833-26-000007.md) | [(6.0)](/filings/0000318833-26-000024.md) | [12.1](/filings/0000318833-26-000054.md) | [1.3](/filings/0000318833-25-000070.md) | [6.6 d](/filings/0000318833-26-000007.md) | [(3.4)](/filings/0000318833-26-000024.md) | [2.2](/filings/0000318833-26-000054.md) |
| Interest expense | $m | [10.1](/filings/0000318833-24-000074.md) | [11.7 d](/filings/0000318833-25-000015.md) | [12.1](/filings/0000318833-25-000037.md) | [11.9](/filings/0000318833-25-000057.md) | [11.8](/filings/0000318833-25-000070.md) | [12.0 d](/filings/0000318833-26-000007.md) | [11.4](/filings/0000318833-26-000024.md) | [11.9](/filings/0000318833-26-000054.md) | [11.9](/filings/0000318833-25-000070.md) | [9.5 d](/filings/0000318833-26-000007.md) | [8.9](/filings/0000318833-26-000024.md) | [9.3](/filings/0000318833-26-000054.md) |
| Income tax | $m | [1.1](/filings/0000318833-24-000074.md) | [0.6 d](/filings/0000318833-25-000015.md) | [0.1](/filings/0000318833-25-000037.md) | [1.5](/filings/0000318833-25-000057.md) | [0.5](/filings/0000318833-25-000070.md) | [1.2 d](/filings/0000318833-26-000007.md) | [0.2](/filings/0000318833-26-000024.md) | [1.0](/filings/0000318833-26-000054.md) | [0.9](/filings/0000318833-25-000070.md) | [0.4 d](/filings/0000318833-26-000007.md) | [0.0](/filings/0000318833-26-000024.md) | [(0.1)](/filings/0000318833-26-000054.md) |
| Net income | $m | [(12.1)](/filings/0000318833-24-000074.md) | [(23.1) d](/filings/0000318833-25-000015.md) | [(17.2)](/filings/0000318833-25-000070.md) | [(2.8)](/filings/0000318833-25-000070.md) | [(11.1)](/filings/0000318833-25-000070.md) | [(7.2) d](/filings/0000318833-26-000007.md) | [(29.7)](/filings/0000318833-26-000054.md) | [(4.3)](/filings/0000318833-26-000054.md) | [(11.4)](/filings/0000318833-25-000070.md) | [(3.8) d](/filings/0000318833-26-000007.md) | [(11.3)](/filings/0000318833-26-000054.md) | [(6.8)](/filings/0000318833-26-000054.md) |
| Diluted EPS | $ per share | [(2.78)](/filings/0000318833-24-000074.md) | not reported | [(3.89)](/filings/0000318833-25-000037.md) | [(0.63)](/filings/0000318833-25-000057.md) | [(2.52)](/filings/0000318833-25-000070.md) | not reported | [(6.61)](/filings/0000318833-26-000024.md) | [(0.95)](/filings/0000318833-26-000054.md) | [(2.68)](/filings/0000318833-25-000070.md) | not reported | [(3.12)](/filings/0000318833-26-000024.md) | [(2.15)](/filings/0000318833-26-000054.md) |
| Basic EPS | $ per share | [(2.78)](/filings/0000318833-24-000074.md) | not reported | [(3.89)](/filings/0000318833-25-000037.md) | [(0.63)](/filings/0000318833-25-000057.md) | [(2.52)](/filings/0000318833-25-000070.md) | not reported | [(6.61)](/filings/0000318833-26-000024.md) | [(0.95)](/filings/0000318833-26-000054.md) | [(2.68)](/filings/0000318833-25-000070.md) | not reported | [(3.12)](/filings/0000318833-26-000024.md) | [(2.15)](/filings/0000318833-26-000054.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [21.5](/filings/0000318833-23-000051.md) | [35.4](/filings/0000318833-25-000015.md) | [24.2](/filings/0000318833-24-000036.md) | [22.5](/filings/0000318833-24-000054.md) | [19.1](/filings/0000318833-24-000074.md) | [35.5](/filings/0000318833-26-000007.md) | [16.8](/filings/0000318833-25-000037.md) | [20.7](/filings/0000318833-25-000057.md) | [14.8](/filings/0000318833-25-000070.md) | [18.1](/filings/0000318833-26-000054.md) | [12.8](/filings/0000318833-26-000024.md) | [26.0](/filings/0000318833-26-000054.md) |
| Current assets | $m | [313](/filings/0000318833-23-000051.md) | [322](/filings/0000318833-25-000015.md) | [298](/filings/0000318833-24-000036.md) | [315](/filings/0000318833-24-000054.md) | [315](/filings/0000318833-24-000074.md) | [305](/filings/0000318833-26-000007.md) | [292](/filings/0000318833-25-000037.md) | [326](/filings/0000318833-25-000057.md) | [311](/filings/0000318833-25-000070.md) | [266](/filings/0000318833-26-000054.md) | [266](/filings/0000318833-26-000024.md) | [291](/filings/0000318833-26-000054.md) |
| Total assets | $m | [561](/filings/0000318833-23-000051.md) | [566](/filings/0000318833-25-000015.md) | [535](/filings/0000318833-24-000036.md) | [550](/filings/0000318833-24-000054.md) | [545](/filings/0000318833-24-000074.md) | [528](/filings/0000318833-26-000007.md) | [515](/filings/0000318833-25-000037.md) | [548](/filings/0000318833-25-000057.md) | [531](/filings/0000318833-25-000070.md) | [485](/filings/0000318833-26-000054.md) | [479](/filings/0000318833-26-000024.md) | [499](/filings/0000318833-26-000054.md) |
| Current liabilities | $m | [159](/filings/0000318833-23-000051.md) | [175](/filings/0000318833-25-000015.md) | [171](/filings/0000318833-24-000036.md) | [173](/filings/0000318833-24-000054.md) | [175](/filings/0000318833-24-000074.md) | [171](/filings/0000318833-26-000007.md) | [153](/filings/0000318833-25-000037.md) | [166](/filings/0000318833-25-000057.md) | [160](/filings/0000318833-25-000070.md) | [120](/filings/0000318833-26-000054.md) | [119](/filings/0000318833-26-000024.md) | [127](/filings/0000318833-26-000054.md) |
| Total liabilities | $m | [497](/filings/0000318833-23-000051.md) | [520](/filings/0000318833-25-000015.md) | [509](/filings/0000318833-24-000036.md) | [526](/filings/0000318833-24-000054.md) | [527](/filings/0000318833-24-000074.md) | [527](/filings/0000318833-26-000007.md) | [541](/filings/0000318833-25-000037.md) | [571](/filings/0000318833-25-000057.md) | [499](/filings/0000318833-25-000070.md) | [458](/filings/0000318833-26-000054.md) | [464](/filings/0000318833-26-000024.md) | [491](/filings/0000318833-26-000054.md) |
| Long-term debt | $m | [295](/filings/0000318833-23-000051.md) | [306](/filings/0000318833-25-000015.md) | [301](/filings/0000318833-24-000036.md) | [315](/filings/0000318833-24-000054.md) | [316](/filings/0000318833-24-000074.md) | [320](/filings/0000318833-26-000007.md) | [348](/filings/0000318833-25-000037.md) | [363](/filings/0000318833-25-000057.md) | [295](/filings/0000318833-25-000070.md) | [289](/filings/0000318833-26-000054.md) | [298](/filings/0000318833-26-000024.md) | [318](/filings/0000318833-26-000054.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [64.6](/filings/0000318833-24-000074.md) | [45.6](/filings/0000318833-26-000007.md) | [26.3](/filings/0000318833-25-000070.md) | [23.9](/filings/0000318833-25-000070.md) | [17.9](/filings/0000318833-25-000070.md) | [1.7](/filings/0000318833-26-000054.md) | [(26.0)](/filings/0000318833-26-000054.md) | [(22.9)](/filings/0000318833-26-000054.md) | [(17.7)](/filings/0000318833-25-000070.md) | [(24.5)](/filings/0000318833-26-000054.md) | [(39.4)](/filings/0000318833-26-000054.md) | [(49.7)](/filings/0000318833-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.5 d](/filings/0000318833-24-000074.md) | [11.1 d](/filings/0000318833-25-000015.md) | [1.9](/filings/0000318833-25-000037.md) | [(6.4) d](/filings/0000318833-25-000057.md) | [5.6 d](/filings/0000318833-25-000070.md) | [21.6 d](/filings/0000318833-26-000007.md) | [(28.7)](/filings/0000318833-26-000024.md) | [(3.3) d](/filings/0000318833-26-000054.md) | [3.9 d](/filings/0000318833-25-000070.md) | [16.8 d](/filings/0000318833-26-000007.md) | [(9.1)](/filings/0000318833-26-000024.md) | [0.7 d](/filings/0000318833-26-000054.md) |
| Capital expenditure | $m | [1.8](/filings/0000318833-24-000074.md) | [3.0 d](/filings/0000318833-25-000015.md) | [3.0](/filings/0000318833-25-000037.md) | [2.9](/filings/0000318833-25-000057.md) | [1.2](/filings/0000318833-25-000070.md) | [2.0 d](/filings/0000318833-26-000007.md) | [1.4](/filings/0000318833-26-000024.md) | [3.3](/filings/0000318833-25-000057.md) | [2.9](/filings/0000318833-25-000070.md) | [2.1 d](/filings/0000318833-26-000007.md) | [2.4](/filings/0000318833-26-000024.md) | [4.0 d](/filings/0000318833-26-000054.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [43.2](/filings/0000318833-22-000099.md) | [4.3](/filings/0000318833-24-000036.md) | [4.4](/filings/0000318833-24-000054.md) | [4.4](/filings/0000318833-24-000074.md) | [4.4](/filings/0000318833-25-000037.md) | [4.4](/filings/0000318833-25-000057.md) | [4.4](/filings/0000318833-25-000070.md) | [4.5](/filings/0000318833-26-000024.md) | [4.5](/filings/0000318833-26-000054.md) | [4.5](/filings/0000318833-25-000070.md) | [4.6](/filings/0000318833-26-000024.md) | [4.6](/filings/0000318833-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,583,209 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0000318833-26-000054.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.